Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007.
暂无分享,去创建一个
[1] A. Criego,et al. Eating Disorders and Diabetes , 2009, Diabetes Spectrum.
[2] Eve Roelker,et al. Screening for Coronary Artery Disease in Patients With Diabetes , 2008 .
[3] R. Rubin,et al. Behavioral and Psychosocial Interventions in Diabetes , 2007, Diabetes Care.
[4] Yoon K Loke,et al. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. , 2007, JAMA.
[5] Inder Singh,et al. High-density lipoprotein as a therapeutic target: a systematic review. , 2007, JAMA.
[6] P. Mehler,et al. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial , 2007, Nature Clinical Practice Nephrology.
[7] J. Krinsley. Glycemic control in critically ill patients: Leuven and beyond. , 2007, Chest.
[8] Dana Dabelea,et al. Incidence of diabetes in youth in the United States. , 2007, JAMA.
[9] K. Wolski,et al. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.
[10] Susan Smyth,et al. Aspirin dose for the prevention of cardiovascular disease: a systematic review. , 2007, JAMA.
[11] Rajiv Raman,et al. The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy , 2007, Diabetes Care.
[12] K. Reinhart,et al. Intensive insulin therapy in the ICU: benefit versus harm? , 2007, Intensive Care Medicine.
[13] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[14] G. Bray,et al. Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.
[15] H. Gerstein. Point: If It Is Important to Prevent Type 2 Diabetes, It Is Important to Consider All Proven Therapies Within a Comprehensive Approach , 2007, Diabetes Care.
[16] J. Bosch,et al. Association of diabetes‐related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[17] P. Cryer. Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes , 2007, Diabetes Care.
[18] Kathleen N Lohr,et al. Systematic Review: Smoking Cessation Intervention Strategies for Adults and Adults in Special Populations , 2006, Annals of Internal Medicine.
[19] R. Radermecker. Intensive Insulin Therapy in the Intensive Care Unit: Assessment by Continuous Glucose Monitoring , 2006, Diabetes Care.
[20] M. Molitch,et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[21] D. Mikhailidis,et al. Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) , 2006, Diabetes Care.
[22] B. Davis,et al. Abstract 2734: Heart Failure with Preserved and Impaired Left Ventricular Systolic Function in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2006 .
[23] Rodney A Hayward,et al. Narrative Review: Lack of Evidence for Recommended Low-Density Lipoprotein Treatment Targets: A Solvable Problem , 2006, Annals of Internal Medicine.
[24] Desmond E. Williams,et al. The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study , 2006, Pediatrics.
[25] M. Laakso,et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.
[26] C. Apovian,et al. Nutrition Recommendations and Interventions for Diabetes–2006 , 2006, Diabetes Care.
[27] S. Braithwaite,et al. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. , 2006, The American journal of cardiology.
[28] K. Shojania,et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. , 2006, JAMA.
[29] A. Mooradian,et al. Narrative Review: A Rational Approach to Starting Insulin Therapy , 2006, Annals of Internal Medicine.
[30] S. Hernández-Díaz,et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. , 2006, The New England journal of medicine.
[31] M. Phillip,et al. Insulin Pump Therapy in Youth With Type 1 Diabetes: A Retrospective Paired Study , 2006, Pediatrics.
[32] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.
[33] T. Horsley,et al. Effectiveness of community health workers in the care of persons with diabetes , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[34] G. Remuzzi,et al. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. , 2006, Journal of the American Society of Nephrology : JASN.
[35] M. Mclean,et al. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. , 2006, Diabetes care.
[36] M. Briel,et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.
[37] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[38] J. Albers,et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. , 2006, Diabetes care.
[39] C. Snehalatha,et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.
[40] A. Avogaro,et al. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. , 2006, Journal of the American College of Cardiology.
[41] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[42] P Glasziou,et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.
[43] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[44] R. Collins,et al. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). , 2005, Diabetes care.
[45] Jay R. Desai,et al. Randomized trial of quality improvement intervention to improve diabetes care in primary care settings. , 2005, Diabetes care.
[46] J. Mahoney. Reducing patient drug acquisition costs can lower diabetes health claims. , 2005, The American journal of managed care.
[47] Patrick J O'Connor,et al. Factors driving diabetes care improvement in a large medical group: ten years of progress. , 2005, The American journal of managed care.
[48] H. Kramer,et al. Screening for kidney disease in adults with diabetes. , 2005, Diabetes care.
[49] L. Bouter,et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. , 2005, Diabetes care.
[50] M. C. Leske,et al. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. , 2005, Ophthalmology.
[51] Roberto Sega,et al. Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.
[52] R. Freeman,et al. Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.
[53] J Herlitz,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.
[54] J. Rosenstock,et al. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. , 2005, Diabetes care.
[55] W. Herman,et al. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. , 2005, Diabetes care.
[56] Jonathan J Shuster,et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. , 2004, Diabetes care.
[57] J. Lau,et al. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. , 2004, Archives of internal medicine.
[58] K. Borch-Johnsen,et al. Preventive cardiology: abstractVery low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes☆ , 2004 .
[59] F. Kaufman,et al. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. , 2004, The Journal of pediatrics.
[60] Carmen Castaneda-Sceppa,et al. Physical activity/exercise and type 2 diabetes. , 2004, Diabetes care.
[61] Neil R. Powe,et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.
[62] M. Pfeffer,et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. , 2004, JAMA.
[63] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[64] Daniel H Solomon,et al. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. , 2004, Archives of internal medicine.
[65] Judith Wylie-Rosett,et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. , 2004, Diabetes care.
[66] E. Barrett,et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.
[67] C. Schmid,et al. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. , 2004, Archives of internal medicine.
[68] W. Tamborlane,et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. , 2004, Diabetes care.
[69] R. Misbin. The phantom of lactic acidosis due to metformin in patients with diabetes. , 2004, Diabetes care.
[70] Mark R Conaway,et al. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. , 2004, Diabetes care.
[71] M. Rewers,et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.
[72] P. Cryer. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. , 2004, The New England journal of medicine.
[73] E. Gracely,et al. The Effects of Low-Carbohydrate versus Conventional Weight Loss Diets in Severely Obese Adults: One-Year Follow-up of a Randomized Trial , 2004, Annals of Internal Medicine.
[74] Prakash L Mokshagundam. Perioperative Management of Diabetes Mellitus , 2004, Critical care nursing quarterly.
[75] Gilles Chatellier,et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. , 2004, JAMA.
[76] Paul Schoenhagen,et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.
[77] M. Rewers,et al. Celiac disease associated with type 1 diabetes mellitus. , 2004, Endocrinology and metabolism clinics of North America.
[78] M. Porta,et al. A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. , 2004, Diabetes care.
[79] Irl B Hirsch,et al. Management of diabetes and hyperglycemia in hospitals. , 2004, Diabetes care.
[80] S. Saydah,et al. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.
[81] Carl J Pepine,et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. , 2003, JAMA.
[82] M. Roncaglioni,et al. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. , 2003, Diabetes care.
[83] E. Salpeter,et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. , 2003, Archives of internal medicine.
[84] Lee Hebert,et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[85] M. Pfeffer,et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme , 2003, The Lancet.
[86] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.
[87] M. Pfeffer,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial , 2003, The Lancet.
[88] B. Zinman,et al. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. , 2003, Diabetes care.
[89] Stanton Newman,et al. A systematic review of psychosocial outcomes following education, self-management and psychological interventions in diabetes mellitus. , 2003, Patient education and counseling.
[90] Malinda Peeples,et al. Diabetes Self-Management Education Core Outcomes Measures , 2003, The Diabetes educator.
[91] G. Eknoyan,et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.
[92] R. Sigal,et al. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus , 2003, Diabetologia.
[93] M. Franz,et al. How effective is medical nutrition therapy in diabetes care? , 2003, Journal of the American Dietetic Association.
[94] B. McCrindle,et al. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. , 2003, The Journal of pediatrics.
[95] Quan Dong Nguyen,et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.
[96] D. Rader,et al. A randomized trial of a low-carbohydrate diet for obesity. , 2003, The New England journal of medicine.
[97] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[98] Thomas Lumley,et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.
[99] I. Hirsch,et al. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. , 2003, JAMA.
[100] E. Guallar,et al. Meta-Analysis of Randomized Educational and Behavioral Interventions in Type 2 Diabetes , 2003, The Diabetes educator.
[101] G. Grunkemeier,et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[102] C. Mangione,et al. Guidelines for improving the care of the older person with diabetes mellitus. , 2003, Journal of the American Geriatrics Society.
[103] M. Pfeffer,et al. Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy , 2003, Annals of Internal Medicine.
[104] Patrick J O'Connor,et al. Electronic medical records and diabetes care improvement: are we waiting for Godot? , 2003, Diabetes care.
[105] David M Nathan,et al. A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. , 2003, Diabetes care.
[106] M. Cakir,et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2003, The Journal of clinical endocrinology and metabolism.
[107] Russell Harris,et al. Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force , 2003, Annals of Internal Medicine.
[108] Miet Schetz,et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.
[109] R. Klein,et al. Screening interval for retinopathy in type 2 diabetes , 2003, The Lancet.
[110] Simon P Harding,et al. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study , 2003, The Lancet.
[111] J. Kastelein,et al. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. , 2002, Journal of the American College of Cardiology.
[112] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[113] C. Castaneda,et al. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. , 2002, Diabetes care.
[114] G. Holmes,et al. Screening for coeliac disease in type 1 diabetes , 2002, Archives of disease in childhood.
[115] Catherine Kim,et al. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.
[116] N. Levinsky. Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late , 2002, Annals of Internal Medicine.
[117] Deepak L. Bhatt,et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. , 2002, The American journal of cardiology.
[118] A. Ceriello,et al. Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation: Effects of Short- and Long-Term Simvastatin Treatment , 2002, Circulation.
[119] K. Freedland,et al. Anxiety and Poor Glycemic Control: A Meta-Analytic Review of the Literature , 2002, International journal of psychiatry in medicine.
[120] T. Buchanan,et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.
[121] S. Grundy,et al. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. , 2002, Archives of internal medicine.
[122] H. Parving,et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. , 2002, Kidney international.
[123] C. Schmid,et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. , 2002, Diabetes care.
[124] M. Laakso,et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.
[125] O. Kordonouri,et al. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[126] P. Cryer,et al. Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes* , 2002, Diabetologia.
[127] Steven Snapinn,et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.
[128] M. Franz,et al. The evidence for the effectiveness of medical nutrition therapy in diabetes management. , 2002, Diabetes care.
[129] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[130] G. Bakris,et al. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease , 2002, Vascular medicine.
[131] D. Kendall,et al. Assessment of group versus individual diabetes education: a randomized study. , 2002, Diabetes care.
[132] Terho Lehtimäki,et al. Carotid artery intima-media thickness in children with type 1 diabetes. , 2002, Diabetes.
[133] D. Goldstein,et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.
[134] R. Sigal,et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.
[135] U. S. P. S. T. Force,et al. Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale , 2002, Annals of Internal Medicine.
[136] Nina Singh,et al. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.
[137] A. Mohn,et al. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[138] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[139] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[140] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[141] C. D. Miller,et al. Hypoglycemia in patients with type 2 diabetes mellitus. , 2001, Archives of internal medicine.
[142] J. Cornel,et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. , 2001, International journal of cardiology.
[143] N. Hollenberg. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. , 2001, Current hypertension reports.
[144] L. Kuller,et al. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. , 2001, Diabetes care.
[145] R. Meek,et al. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. , 2001, Diabetes care.
[146] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[147] M Peyrot,et al. Psychological issues and treatments for people with diabetes. , 2001, Journal of clinical psychology.
[148] S. Norris,et al. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. , 2001, Diabetes care.
[149] P. Valensi,et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. , 2001, Diabetes care.
[150] G. Bakris,et al. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. , 2000, Kidney international.
[151] D. Hunninghake,et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. , 2000, JAMA.
[152] G. Bakris,et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[153] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[154] John S Yudkin,et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.
[155] Diabetes Control. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. , 2000, Diabetes care.
[156] R. Hanson,et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. , 2000, Diabetes care.
[157] Michael A Weiss,et al. National Standards for Diabetes Self-Management Education , 2000, Diabetes Care.
[158] H. Gerstein,et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.
[159] R. Hayward,et al. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. , 2000, JAMA.
[160] Matthew D. Davis,et al. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.
[161] S. Yusuf,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[162] K. Jablonski,et al. Effect of physician specialty on outcomes in diabetic ketoacidosis. , 1999, Diabetes care.
[163] D. Nathan,et al. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. , 1999, Diabetes care.
[164] F. Brancati,et al. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. , 1999, Diabetes care.
[165] R. Holl,et al. Thyroid Autoimmunity in Children and Adolescents with Type 1 Diabetes mellitus , 1999, Hormone Research in Paediatrics.
[166] Ames,et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.
[167] A. Donker,et al. The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[168] J. Viikari,et al. Serum cholesterol ester fatty acids in 7‐ and 13‐month‐old children in a prospective randomized trial of a low‐saturated fat, low‐cholesterol diet: the STRIP baby project , 1999, Acta paediatrica.
[169] D. Schriger,et al. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. , 1999, JAMA.
[170] P. Kris-Etherton,et al. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. , 1999, The American journal of clinical nutrition.
[171] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[172] B. Zinman,et al. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. , 1999, Diabetes care.
[173] G. Grunkemeier,et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. , 1999, The Annals of thoracic surgery.
[174] B. Davis,et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.
[175] G. Reiber,et al. Preventive Foot Care in People With Diabetes , 1998, Diabetes Care.
[176] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[177] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[178] B. Metzger,et al. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. , 1998, Diabetes care.
[179] Y. Friedlander,et al. Hypoglycemia in Hospitalized Nondiabetic Older Patients , 1998, Journal of the American Geriatrics Society.
[180] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[181] T A Louis,et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[182] R. Schrier,et al. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[183] R. Newton,et al. The comparison of four weight reduction strategies aimed at overweight patients with diabetes mellitus: four‐year follow‐up , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[184] M. Pahor,et al. Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM , 1998, Diabetes Care.
[185] J. Pomposelli,et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. , 1998, JPEN. Journal of parenteral and enteral nutrition.
[186] D. Andrewes,et al. Neuropsychological Complications of IDDM in Children 2 Years After Disease Onset , 1998, Diabetes Care.
[187] G. A. Fleming,et al. Lactic acidosis in patients with diabetes treated with metformin. , 1998, The New England journal of medicine.
[188] P. O S I T I O N S T A T E M E N T. Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.
[189] J. L. Botha,et al. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes , 1997, Epidemiology and Infection.
[190] J. Colwell. Aspirin Therapy in Diabetes , 1997, Diabetes Care.
[191] J. Ivy. Role of Exercise Training in the Prevention and Treatment of Insulin Resistance and Non-Insulin-Dependent Diabetes Mellitus , 1997, Sports medicine.
[192] L. Poretsky,et al. Effects of an Intervention by a Diabetes Team in Hospitalized Patients With Diabetes , 1997, Diabetes Care.
[193] K. Malmberg. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.
[194] J. Rovet,et al. Attentional Functioning in Children and Adolescents With IDDM , 1997, Diabetes Care.
[195] G. Bray,et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.
[196] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[197] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.
[198] H. Parving,et al. Population based study of rates of multiple pregnancies in denmark, 1980-94 , 1997, BMJ.
[199] F. Brancati,et al. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. , 1997, Archives of internal medicine.
[200] B. Psaty,et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.
[201] G. Grunkemeier,et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. , 1997, The Annals of thoracic surgery.
[202] T. Sand,et al. Cognitive function in Type 1 diabetic children with and without episodes of severe hypoglycaemia , 1997, Acta paediatrica.
[203] B. Davis,et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.
[204] B. Sibai. Treatment of hypertension in pregnant women. , 1996, The New England journal of medicine.
[205] T. Buchanan,et al. Pre-Conception Care of Diabetes, Congenital Malformations, and Spontaneous Abortions , 1996, Diabetes Care.
[206] M. Lishner,et al. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. , 1996, Archives of internal medicine.
[207] J. McGill,et al. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. , 1995, The American journal of medicine.
[208] C. Levetan,et al. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. , 1995, The American journal of medicine.
[209] J Herlitz,et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.
[210] E. Araki,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.
[211] R. Klein. Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.
[212] J. Duncan,et al. Efficacy of sliding-scale insulin therapy: a comparison with prospective regimens. , 1994, Family practice research journal.
[213] M. Laakso,et al. NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.
[214] B. Zinman,et al. Exercise in Individuals With IDDM , 1994, Diabetes Care.
[215] R. Glasgow,et al. A Systematic Approach to Diabetes Management in the Post-DCCT Era , 1994, Diabetes Care.
[216] C. Tsalamandris,et al. Progressive Decline in Renal Function in Diabetic Patients With and Without Albuminuria , 1994, Diabetes.
[217] P. Reichard,et al. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.
[218] G. Palomaki,et al. The Impact of Preconception Counseling on Pregnancy Outcomes: The experience of the Maine Diabetes in Pregnancy Program , 1993, Diabetes Care.
[219] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[220] R. Rubin,et al. Psychosocial Problems and Interventions in Diabetes: A review of the literature , 1992, Diabetes Care.
[221] M. Feinglos,et al. Stress and Diabetes Mellitus , 1992, Diabetes Care.
[222] R. Klein,et al. Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.
[223] J. Khoury,et al. Pre‐conception management of insulin‐dependent diabetes: Improvement of pregnancy outcome , 1991, Obstetrics and gynecology.
[224] M. Vray,et al. Risk/benefit ratio of changing late obstetrical strategies in the management of insulin-dependent diabetic pregnancies. A comparison between 1971-1977 and 1978-1985 periods in 389 pregnancies. , 1991, Diabete & metabolisme.
[225] L. Gavin,et al. Preconception care of diabetes. Glycemic control prevents congenital anomalies. , 1991, JAMA.
[226] J. Miller,et al. Assessing family sharing of diabetes responsibilities. , 1990, Journal of pediatric psychology.
[227] H. Chase,et al. Thyroid Hormone Replacement and Growth of Children with Subclinical Hypothyroidism and Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[228] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[229] J. Stamler,et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.
[230] P. Cryer,et al. Psychiatric Illness in Diabetes Mellitus: Relationship to Symptoms and Glucose Control , 1986, The Journal of nervous and mental disease.
[231] J. Newman,et al. Hypoglycemia in hospitalized patients. Causes and outcomes. , 1986, The New England journal of medicine.
[232] M. Karp,et al. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. , 1986, American journal of obstetrics and gynecology.
[233] D. DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.
[234] W. A. Müller,et al. Metabolic and hormonal effects of muscular exercise in juvenile type diabetics , 1977, Diabetologia.
[235] W. Howard. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study , 2008 .
[236] L. Kennedy,et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .
[237] J. Leahy. Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care , 2008 .
[238] J. Boucher,et al. Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional. , 2007, Journal of the American Dietetic Association.
[239] B. Sears. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women. , 2007, MedGenMed : Medscape general medicine.
[240] R. Eckel,et al. Mellitus: A Scientific Statement From the American Heart Association and the Primary Prevention of Cardiovascular Diseases in People With Diabetes , 2007 .
[241] Diabetes care in the school and day care setting. , 2007, Diabetes care.
[242] M. Roizen. Intensive Insulin Therapy in the Medical ICU , 2007 .
[243] R. Bergenstal. Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 diabetes. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[244] L. Blonde,et al. The Hurricane Katrina aftermath and its impact on diabetes care: observations from "ground zero": lessons in disaster preparedness of people with diabetes. , 2006, Diabetes care.
[245] L. Siminerio. Implementing diabetes self-management training programs: breaking through the barriers in primary care. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[246] Howard Zisser,et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. , 2006, Diabetes care.
[247] W. Frishman. Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATEECLA Randomized Controlled Trial , 2006 .
[248] M. Davidson,et al. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. , 2005, The American journal of cardiology.
[249] C. Schmid,et al. Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. , 2005, American journal of preventive medicine.
[250] A. Gotto. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. , 2005, The Journal of pediatrics.
[251] I. Hirsch,et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[252] Theodore Speroff,et al. Diabetes patient education: a meta-analysis and meta-regression. , 2004, Patient education and counseling.
[253] S. Grundy,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. , 2004, Journal of the American College of Cardiology.
[254] Michael Miller. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[255] J. Klein,et al. Screening for type 2 diabetes mellitus in adults: recommendations and rationale. , 2003, Annals of internal medicine.
[256] Pd redaction. Screening for type 2 diabetes. , 2003, Diabetes care.
[257] Philip Raskin,et al. The treatment of hypertension in adult patients with diabetes. , 2002, Diabetes care.
[258] Arshag D Mooradian,et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2002, Diabetes care.
[259] S. Braithwaite,et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[260] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[261] T. Sano,et al. [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[262] Lead Visual Information Specialist , 2001 .
[263] G. Bray,et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.
[264] Orton,et al. EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .
[265] Illiam,et al. THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .
[266] Steven A. Smith,et al. Use of influenza and pneumococcal vaccines in people with diabetes. , 2000, Diabetes care.
[267] Usdhhs. Physical Activity and Health: A Report of the Surgeon General , 1996 .
[269] Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. , 1995, Kidney international.
[270] A. Fournier,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.
[271] Hypoglycemia in hospitalized patients. , 1987, The New England journal of medicine.
[272] Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. , 1985, Archives of ophthalmology.
[273] Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial , 2022 .
[274] Dang Qing,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .